NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Thiazolidinediones


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
AACE Releases New Diabetes Algorithm for Treatment of Patients with Type 2 Diabetes
2009 NOV 2 ... medications. These drug classes include biguanides, DPP-4 inhibitors, incretin mimetics, thiazolidinediones, a-glucosidase inhibitors, sulfonylureas, meglitinides, bile acid sequestrants, amylin ...
Subject: Type 2 Diabetes
Price: $3.00
*
Data from L. Blonde and colleagues advance knowledge in type 2 diabetes
2009 NOV 1 ... a study "To assess the efficacy and tolerability of vildagliptin compared with thiazolidinediones (TZDs) as an add on to metformin treatment in a primary care patient population with ...
Subject: Type 2 Diabetes
Price: $3.00
*
Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference
2009 OCT 12 ... on a stable treatment regimen of diet and exercise or treatment with metformin and/or thiazolidinediones. The study included 4 dose arms to which patients were randomized to receive 10 mcg/day, ...
Subject: Type 2 Diabetes
Price: $3.00
*
Investigators at University of Minnesota have published new data on obesity and diabetes
2009 NOV 23 ... to characterize the obese adipose secretory proteins that are responsive to the thiazolidinediones class of PPAR-gamma agonizts," investigators in the United States report. ...
Subject: Obesity and Diabetes
Price: $3.00
*
New diabetes study results from S.G. Jones et al described
2009 SEP 28 ... increased 2% for every year increase in age. Patients with diabetes using thiazolidinediones, regardless of type, had higher proportions of distal upper and lower limb fractures ...
Subject: Diabetes
Price: $3.00
*
New surgery study findings have been reported from H.S. Sacks et al
2009 OCT 19 ... fat UCP-1, PRDM16, and PGC1-alpha mRNAs were similar in diabetics treated with thiazolidinediones compared to diabetics not treated with...
Subject: Surgery
Price: $3.00
*
Research conducted at University of Guelph has updated our knowledge about women's health
2009 NOV 23 ... profile of polycystic ovarian syndrome (PCOS) and recent studies have shown that thiazolidinediones such as rosiglitazone improve fertility in women with PCOS but the mechanism is not well ...
Subject: Women's Health
Price: $3.00
*
Research from University of Montreal yields new data on metabolism
2009 SEP 21 ... "Thiazolidinediones (TZDs) have beneficial effects on glucose homeostasis via enhancement of insulin ...
Subject: Metabolism
Price: $3.00
*
Research on life sciences detailed by scientists at Merck & Company, Inc.
2009 NOV 9 ... in HbA1c (A1C) than studies of patients treated with sitagliptin. However, studies of thiazolidinediones tended to enroll patients with higher baseline A1C levels." "This ...
Subject: Life Sciences
View Free
Daily News
Article
Research on life sciences discussed by scientists at University of British Columbia
2009 SEP 21 ... mellitus, increases the risk of fractures in women. The association between the use of thiazolidinediones and fractures in men and women is not adequately understood." "We ...
Subject: Life Sciences
Price: $3.00
*
Research on life sciences published by T.K. Hoffmann et al
2009 SEP 28 ... include statins, niacin, fibric acid derivatives, bile acid sequestrants, ezetimibe, thiazolidinediones, and aspirin," wrote T.K. Hoffmann and colleagues. The researchers ...
Subject: Life Sciences
Price: $3.00
*
Researchers at University of Birmingham target diabetes
2009 SEP 28 ... scientists writing in the British Journal of General Practice report. "Thiazolidinediones, or glitazones, have been used for the treatment of diabetes for a decade. Rosiglitazone ...
Subject: Diabetes
Price: $3.00
*
Researchers from Aarhus University report recent findings in life sciences
2009 NOV 16 ... "Thiazolidinediones (TZDs) are insulin sensitizing drugs used to treat type 2 diabetes. The primary target ...
Subject: Life Sciences
Price: $3.00
*
Studies in the area of diabetes risk factors reported from Baylor College of Medicine
2009 OCT 19 ... For high-risk patients and those who progress despite intensive lifestyle modification, thiazolidinediones are also recommended," wrote M.D. Sharma and colleagues, Baylor College of Medicine. ...
Subject: Diabetes Risk Factors
Price: $3.00
*
Study data from S. Brunton and colleagues update understanding of obesity and diabetes
2009 NOV 23 ... of type 2 diabetes. Most conventional antidiabetes agents, including sulfonylureas, thiazolidinediones, and insulin, improve glycemic control but are associated with weight gain or, as with ...
Subject: Obesity and Diabetes
Price: $3.00
*
Study findings from I.J. Douglas et al provide new insights into life sciences
2009 NOV 23 ... who experience a fracture, fracture risk is increased during periods of exposure to thiazolidinediones (both rosiglitazone and pioglitazone) compared with unexposed periods. The increased ...
Subject: Life Sciences
Price: $3.00
*
Study Finds That ONGLYZA saxagliptin When Added to Metformin was Non-Inferior to JANUVIA sitagliptin When Added to Metformin in Reducing Hemoglobin HbA1c in Adults With Type 2 Diabetes Mellitus
2009 OCT 19 ... with commonly prescribed oral anti-diabetic medications - metformin, sulfonylureas or thiazolidinediones (TZD) to significantly reduce HbA1c levels. ONGLYZA has also been approved by the U.S. ...
Subject: Bristol-Myers Squibb Company and AstraZeneca
Price: $3.00
*
Study Finds That ONGLYZA(TM) (saxagliptin) When Added to Metformin was Non-Inferior to JANUVIA (sitagliptin) When Added to Metformin in Reducing Hemoglobin (HbA1c RIGHTPARE
2009 OCT 19 ... with commonly prescribed oral anti-diabetic medications - metformin, sulfonylureas or thiazolidinediones (TZD) to significantly reduce HbA1c levels. ONGLYZA has also been approved by the U.S. ...
Subject: Type 2 Diabetes
Price: $3.00
*
Study results from Yeungnam University update understanding of vascular endothelial growth factor
2009 NOV 23 ... "Thiazolidinediones, peroxisome proliferators-activated receptor gamma (PPAR gamma) ligands, have been ...
Subject: Vascular Endothelial Growth Factor
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login